APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Artemisinin Derivatives

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Artemisinin Derivatives Industry Growth and Trends Forecast to 2032

27 December 2025103 pages

Choose your research edition.

Industry ResearchArtemisinin Derivatives Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Artemisinin Derivatives Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Artemisinin Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artemisinin Derivatives Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Artemisinin Derivatives Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Artemisinin Derivatives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Artemisinin Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Artemisinin Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artemisinin Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Artemisinin Derivatives include Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Shanghai Natural Bio-engineering, Sanofi, Kunming Pharmaceutical, Kerui Nanhai, Guilin Pharmaceutical, Guangxi Xiancaotang Pharmaceutical and Guangxi Xiancaotang, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Artemisinin Derivatives market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Artemisinin Derivatives market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Artemisinin Derivatives market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Artemisinin Derivatives.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Artemisinin Derivatives market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Artemisinin Derivatives Market by Company

Kerui Nanhai Pharmaceutical

Shanghai Natural Bio-engineering Co

Shanghai Natural Bio-engineering

Sanofi

Kunming Pharmaceutical

Kerui Nanhai

Guilin Pharmaceutical

Guangxi Xiancaotang Pharmaceutical

Guangxi Xiancaotang

Novanat Bioresource

KPC Pharmaceuticals

Botanical Extracts EPZ Ltd

ArtemiFlow

Artemisinin Derivatives Segment by Type

Dihydroartemisinin

Artemisunate

Others

Artemisinin Derivatives Segment by Application

Malaria Treatment

Scientific Research

Others

Artemisinin Derivatives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artemisinin Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin Derivatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Artemisinin Derivatives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Artemisinin Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Dihydroartemisinin Table 2. Major Company of Artemisunate Table 3. Major Company of Others Table 4. Global Artemisinin Derivatives Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Artemisinin Derivatives Sales by Type (2021-2026) & (t) Table 6. Global Artemisinin Derivatives Sales Market Share in Volume by Type (2021-2026) Table 7. Global Artemisinin Derivatives Sales by Type (2021-2026) & (US$ Million) Table 8. Global Artemisinin Derivatives Sales Market Share in Value by Type (2021-2026) Table 9. Global Artemisinin Derivatives Price by Type (2021-2026) & (USD/t) Table 10. Global Artemisinin Derivatives Sales by Type (2027-2032) & (t) Table 11. Global Artemisinin Derivatives Sales Market Share in Volume by Type (2027-2032) Table 12. Global Artemisinin Derivatives Sales by Type (2027-2032) & (US$ Million) Table 13. Global Artemisinin Derivatives Sales Market Share in Value by Type (2027-2032) Table 14. Global Artemisinin Derivatives Price by Type (2027-2032) & (USD/t) Table 15. North America Artemisinin Derivatives Sales by Type (2021-2026) & (t) Table 16. North America Artemisinin Derivatives Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Artemisinin Derivatives Sales by Type (2021-2026) & (t) Table 18. Europe Artemisinin Derivatives Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Artemisinin Derivatives Sales by Type (2021-2026) & (t) Table 20. Asia-Pacific Artemisinin Derivatives Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Artemisinin Derivatives Sales by Type (2021-2026) & (t) Table 22. Latin America Artemisinin Derivatives Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Artemisinin Derivatives Sales by Type (2021-2026) & (t) Table 24. Middle East and Africa Artemisinin Derivatives Sales by Type (2021-2026) & (US$ Million) Table 25. Artemisinin Derivatives Industry Trends Table 26. Artemisinin Derivatives Industry Drivers Table 27. Artemisinin Derivatives Industry Opportunities and Challenges Table 28. Artemisinin Derivatives Industry Restraints Table 29. Global Artemisinin Derivatives Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Artemisinin Derivatives Revenue Market Share by Company (2021-2026) Table 31. Global Artemisinin Derivatives Sales by Company (2021-2026) & (t) Table 32. Global Artemisinin Derivatives Sales Share by Company (2021-2026) Table 33. Global Artemisinin Derivatives Market Price by Company (2021-2026) & (USD/t) Table 34. Global Artemisinin Derivatives Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Artemisinin Derivatives Major Company Production Sites and Headquarters Table 36. Global Artemisinin Derivatives Company, Product Type & Application Table 37. Global Artemisinin Derivatives Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Artemisinin Derivatives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Artemisinin Derivatives Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Artemisinin Derivatives Sales by Region (2021-2026) & (t) Table 42. Global Artemisinin Derivatives Sales Market Share in Volume by Region (2021-2026) Table 43. Global Artemisinin Derivatives Sales by Region (2021-2026) & (US$ Million) Table 44. Global Artemisinin Derivatives Sales Market Share in Value by Region (2021-2026) Table 45. Global Artemisinin Derivatives Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 46. Global Artemisinin Derivatives Sales by Region (2027-2032) & (t) Table 47. Global Artemisinin Derivatives Sales Market Share in Volume by Region (2027-2032) Table 48. Global Artemisinin Derivatives Sales by Region (2027-2032) & (US$ Million) Table 49. Global Artemisinin Derivatives Sales Market Share in Value by Region (2027-2032) Table 50. Global Artemisinin Derivatives Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 51. Global Artemisinin Derivatives Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Artemisinin Derivatives Sales by Application (2021-2026) & (t) Table 53. Global Artemisinin Derivatives Sales Market Share in Volume by Application (2021-2026) Table 54. Global Artemisinin Derivatives Sales by Application (2021-2026) & (US$ Million) Table 55. Global Artemisinin Derivatives Sales Market Share in Value by Application (2021-2026) Table 56. Global Artemisinin Derivatives Price by Application (2021-2026) & (USD/t) Table 57. Global Artemisinin Derivatives Sales by Application (2027-2032) & (t) Table 58. Global Artemisinin Derivatives Sales Market Share in Volume by Application (2027-2032) Table 59. Global Artemisinin Derivatives Sales by Application (2027-2032) & (US$ Million) Table 60. Global Artemisinin Derivatives Sales Market Share in Value by Application (2027-2032) Table 61. Global Artemisinin Derivatives Price by Application (2027-2032) & (USD/t) Table 62. North America Artemisinin Derivatives Sales by Application (2021-2026) & (t) Table 63. North America Artemisinin Derivatives Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Artemisinin Derivatives Sales by Application (2021-2026) & (t) Table 65. Europe Artemisinin Derivatives Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Artemisinin Derivatives Sales by Application (2021-2026) & (t) Table 67. Asia-Pacific Artemisinin Derivatives Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Artemisinin Derivatives Sales by Application (2021-2026) & (t) Table 69. Latin America Artemisinin Derivatives Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Artemisinin Derivatives Sales by Application (2021-2026) & (t) Table 71. Middle East and Africa Artemisinin Derivatives Sales by Application (2021-2026) & (US$ Million) Table 72. Kerui Nanhai Pharmaceutical Company Information Table 73. Kerui Nanhai Pharmaceutical Business Overview Table 74. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 75. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product Portfolio Table 76. Kerui Nanhai Pharmaceutical Recent Development Table 77. Shanghai Natural Bio-engineering Co Company Information Table 78. Shanghai Natural Bio-engineering Co Business Overview Table 79. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 80. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product Portfolio Table 81. Shanghai Natural Bio-engineering Co Recent Development Table 82. Shanghai Natural Bio-engineering Company Information Table 83. Shanghai Natural Bio-engineering Business Overview Table 84. Shanghai Natural Bio-engineering Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 85. Shanghai Natural Bio-engineering Artemisinin Derivatives Product Portfolio Table 86. Shanghai Natural Bio-engineering Recent Development Table 87. Sanofi Company Information Table 88. Sanofi Business Overview Table 89. Sanofi Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 90. Sanofi Artemisinin Derivatives Product Portfolio Table 91. Sanofi Recent Development Table 92. Kunming Pharmaceutical Company Information Table 93. Kunming Pharmaceutical Business Overview Table 94. Kunming Pharmaceutical Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 95. Kunming Pharmaceutical Artemisinin Derivatives Product Portfolio Table 96. Kunming Pharmaceutical Recent Development Table 97. Kerui Nanhai Company Information Table 98. Kerui Nanhai Business Overview Table 99. Kerui Nanhai Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 100. Kerui Nanhai Artemisinin Derivatives Product Portfolio Table 101. Kerui Nanhai Recent Development Table 102. Guilin Pharmaceutical Company Information Table 103. Guilin Pharmaceutical Business Overview Table 104. Guilin Pharmaceutical Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 105. Guilin Pharmaceutical Artemisinin Derivatives Product Portfolio Table 106. Guilin Pharmaceutical Recent Development Table 107. Guangxi Xiancaotang Pharmaceutical Company Information Table 108. Guangxi Xiancaotang Pharmaceutical Business Overview Table 109. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 110. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product Portfolio Table 111. Guangxi Xiancaotang Pharmaceutical Recent Development Table 112. Guangxi Xiancaotang Company Information Table 113. Guangxi Xiancaotang Business Overview Table 114. Guangxi Xiancaotang Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 115. Guangxi Xiancaotang Artemisinin Derivatives Product Portfolio Table 116. Guangxi Xiancaotang Recent Development Table 117. Novanat Bioresource Company Information Table 118. Novanat Bioresource Business Overview Table 119. Novanat Bioresource Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 120. Novanat Bioresource Artemisinin Derivatives Product Portfolio Table 121. Novanat Bioresource Recent Development Table 122. KPC Pharmaceuticals Company Information Table 123. KPC Pharmaceuticals Business Overview Table 124. KPC Pharmaceuticals Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 125. KPC Pharmaceuticals Artemisinin Derivatives Product Portfolio Table 126. KPC Pharmaceuticals Recent Development Table 127. Botanical Extracts EPZ Ltd Company Information Table 128. Botanical Extracts EPZ Ltd Business Overview Table 129. Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 130. Botanical Extracts EPZ Ltd Artemisinin Derivatives Product Portfolio Table 131. Botanical Extracts EPZ Ltd Recent Development Table 132. ArtemiFlow Company Information Table 133. ArtemiFlow Business Overview Table 134. ArtemiFlow Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 135. ArtemiFlow Artemisinin Derivatives Product Portfolio Table 136. ArtemiFlow Recent Development Table 137. North America Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 138. North America Artemisinin Derivatives Sales by Country (2021-2026) & (t) Table 139. North America Artemisinin Derivatives Sales Market Share by Country (2021-2026) Table 140. North America Artemisinin Derivatives Sales Forecast by Country (2027-2032) & (t) Table 141. North America Artemisinin Derivatives Sales Market Share Forecast by Country (2027-2032) Table 142. North America Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Artemisinin Derivatives Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Artemisinin Derivatives Market Share by Country (2021-2026) Table 145. North America Artemisinin Derivatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Artemisinin Derivatives Market Share Forecast by Country (2027-2032) Table 147. Europe Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 148. Europe Artemisinin Derivatives Sales by Country (2021-2026) & (t) Table 149. Europe Artemisinin Derivatives Sales Market Share by Country (2021-2026) Table 150. Europe Artemisinin Derivatives Sales Forecast by Country (2027-2032) & (t) Table 151. Europe Artemisinin Derivatives Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Artemisinin Derivatives Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Artemisinin Derivatives Market Share by Country (2021-2026) Table 155. Europe Artemisinin Derivatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Artemisinin Derivatives Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Artemisinin Derivatives Sales by Country (2021-2026) & (t) Table 159. Asia-Pacific Artemisinin Derivatives Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Artemisinin Derivatives Sales Forecast by Country (2027-2032) & (t) Table 161. Asia-Pacific Artemisinin Derivatives Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Artemisinin Derivatives Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Artemisinin Derivatives Market Share by Country (2021-2026) Table 165. Asia-Pacific Artemisinin Derivatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Artemisinin Derivatives Market Share Forecast by Country (2027-2032) Table 167. Latin America Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 168. Latin America Artemisinin Derivatives Sales by Country (2021-2026) & (t) Table 169. Latin America Artemisinin Derivatives Sales Market Share by Country (2021-2026) Table 170. Latin America Artemisinin Derivatives Sales Forecast by Country (2027-2032) & (t) Table 171. Latin America Artemisinin Derivatives Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Artemisinin Derivatives Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Artemisinin Derivatives Market Share by Country (2021-2026) Table 175. Latin America Artemisinin Derivatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Artemisinin Derivatives Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Artemisinin Derivatives Sales by Country (2021-2026) & (t) Table 179. Middle East and Africa Artemisinin Derivatives Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Artemisinin Derivatives Sales Forecast by Country (2027-2032) & (t) Table 181. Middle East and Africa Artemisinin Derivatives Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Artemisinin Derivatives Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Artemisinin Derivatives Market Share by Country (2021-2026) Table 185. Middle East and Africa Artemisinin Derivatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Artemisinin Derivatives Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Artemisinin Derivatives Distributors List Table 190. Artemisinin Derivatives Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Artemisinin Derivatives Image Figure 2. Global Artemisinin Derivatives Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artemisinin Derivatives Market Size (2021-2032) & (US$ Million) Figure 4. Global Artemisinin Derivatives Sales (2021-2032) & (t) Figure 5. Dihydroartemisinin Image Figure 6. Global Dihydroartemisinin Sales YoY Growth (2021-2032) & (t) Figure 7. Artemisunate Image Figure 8. Global Artemisunate Sales YoY Growth (2021-2032) & (t) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (t) Figure 11. Global Artemisinin Derivatives Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Artemisinin Derivatives Market Share by Type 2025 VS 2032 Figure 13. North America Artemisinin Derivatives Sales Market Share in Volume by Type in 2025 Figure 14. North America Artemisinin Derivatives Sales Market Share in Value by Type in 2025 Figure 15. Europe Artemisinin Derivatives Sales Market Share in Volume by Type in 2025 Figure 16. Europe Artemisinin Derivatives Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Artemisinin Derivatives Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Artemisinin Derivatives Sales Market Share in Value by Type in 2025 Figure 19. Latin America Artemisinin Derivatives Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Artemisinin Derivatives Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Artemisinin Derivatives Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Artemisinin Derivatives Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Artemisinin Derivatives Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Malaria Treatment Image Figure 26. Global Malaria Treatment Sales YoY Growth (2021-2032) & (t) Figure 27. Scientific Research Image Figure 28. Global Scientific Research Sales YoY Growth (2021-2032) & (t) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (t) Figure 31. Global Artemisinin Derivatives Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Artemisinin Derivatives Market Share by Application 2025 VS 2032 Figure 33. North America Artemisinin Derivatives Sales Market Share in Volume by Application in 2025 Figure 34. North America Artemisinin Derivatives Sales Market Share in Value by Application in 2025 Figure 35. Europe Artemisinin Derivatives Sales Market Share in Volume by Application in 2025 Figure 36. Europe Artemisinin Derivatives Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Artemisinin Derivatives Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Artemisinin Derivatives Sales Market Share in Value by Application in 2025 Figure 39. Latin America Artemisinin Derivatives Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Artemisinin Derivatives Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Artemisinin Derivatives Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Artemisinin Derivatives Sales Market Share in Value by Application in 2025 Figure 43. North America Artemisinin Derivatives Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 44. North America Artemisinin Derivatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Artemisinin Derivatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Artemisinin Derivatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Artemisinin Derivatives Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 48. Europe Artemisinin Derivatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Artemisinin Derivatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Artemisinin Derivatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Artemisinin Derivatives Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 52. Asia-Pacific Artemisinin Derivatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Artemisinin Derivatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Artemisinin Derivatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Artemisinin Derivatives Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 56. Latin America Artemisinin Derivatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Artemisinin Derivatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Artemisinin Derivatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Artemisinin Derivatives Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 60. Middle East and Africa Artemisinin Derivatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Artemisinin Derivatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Artemisinin Derivatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Artemisinin Derivatives Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Artemisinin Derivatives Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Dihydroartemisinin
  • Artemisunate
  • Others
Applications
  • Malaria Treatment
  • Scientific Research
  • Others
Companies covered
  • Kerui Nanhai Pharmaceutical
  • Shanghai Natural Bio-engineering Co
  • Shanghai Natural Bio-engineering
  • Sanofi
  • Kunming Pharmaceutical
  • Kerui Nanhai
  • Guilin Pharmaceutical
  • Guangxi Xiancaotang Pharmaceutical
  • Guangxi Xiancaotang
  • Novanat Bioresource
  • KPC Pharmaceuticals
  • Botanical Extracts EPZ Ltd
  • ArtemiFlow

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Artemisinin Derivatives Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Artemisinin Derivatives Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Artemisinin Derivatives Market by Type
  6. 1.3.1 Dihydroartemisinin
  7. 1.3.2 Artemisunate
  8. 1.3.3 Others
  9. 1.4 Global Artemisinin Derivatives Market Size by Type
  10. 1.4.1 Global Artemisinin Derivatives Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Artemisinin Derivatives Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Artemisinin Derivatives Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Artemisinin Derivatives Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Artemisinin Derivatives Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Artemisinin Derivatives Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Artemisinin Derivatives Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Artemisinin Derivatives Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Artemisinin Derivatives Industry Trends
  2. 2.2 Artemisinin Derivatives Industry Drivers
  3. 2.3 Artemisinin Derivatives Industry Opportunities and Challenges
  4. 2.4 Artemisinin Derivatives Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Artemisinin Derivatives Revenue (2021-2026)
  2. 3.2 Global Top Players by Artemisinin Derivatives Sales (2021-2026)
  3. 3.3 Global Top Players by Artemisinin Derivatives Price (2021-2026)
  4. 3.4 Global Artemisinin Derivatives Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Artemisinin Derivatives Major Company Production Sites & Headquarters
  6. 3.6 Global Artemisinin Derivatives Company, Product Type & Application
  7. 3.7 Global Artemisinin Derivatives Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Artemisinin Derivatives Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Artemisinin Derivatives Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Artemisinin Derivatives Tier 1, Tier 2, and Tier 3
4 Artemisinin Derivatives Regional Status and Outlook
  1. 4.1 Global Artemisinin Derivatives Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Artemisinin Derivatives Historic Market Size by Region
  3. 4.2.1 Global Artemisinin Derivatives Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Artemisinin Derivatives Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Artemisinin Derivatives Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Artemisinin Derivatives Forecasted Market Size by Region
  7. 4.3.1 Global Artemisinin Derivatives Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Artemisinin Derivatives Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Artemisinin Derivatives Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Artemisinin Derivatives by Application
  1. 5.1 Artemisinin Derivatives Market by Application
  2. 5.1.1 Malaria Treatment
  3. 5.1.2 Scientific Research
  4. 5.1.3 Others
  5. 5.2 Global Artemisinin Derivatives Market Size by Application
  6. 5.2.1 Global Artemisinin Derivatives Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Artemisinin Derivatives Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Artemisinin Derivatives Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Artemisinin Derivatives Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Artemisinin Derivatives Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Artemisinin Derivatives Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Artemisinin Derivatives Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Artemisinin Derivatives Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Kerui Nanhai Pharmaceutical
  2. 6.1.1 Kerui Nanhai Pharmaceutical Company Information
  3. 6.1.2 Kerui Nanhai Pharmaceutical Business Overview
  4. 6.1.3 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product Portfolio
  6. 6.1.5 Kerui Nanhai Pharmaceutical Recent Developments
  7. 6.2 Shanghai Natural Bio-engineering Co
  8. 6.2.1 Shanghai Natural Bio-engineering Co Company Information
  9. 6.2.2 Shanghai Natural Bio-engineering Co Business Overview
  10. 6.2.3 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product Portfolio
  12. 6.2.5 Shanghai Natural Bio-engineering Co Recent Developments
  13. 6.3 Shanghai Natural Bio-engineering
  14. 6.3.1 Shanghai Natural Bio-engineering Company Information
  15. 6.3.2 Shanghai Natural Bio-engineering Business Overview
  16. 6.3.3 Shanghai Natural Bio-engineering Artemisinin Derivatives Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Natural Bio-engineering Artemisinin Derivatives Product Portfolio
  18. 6.3.5 Shanghai Natural Bio-engineering Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Artemisinin Derivatives Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Artemisinin Derivatives Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Kunming Pharmaceutical
  26. 6.5.1 Kunming Pharmaceutical Company Information
  27. 6.5.2 Kunming Pharmaceutical Business Overview
  28. 6.5.3 Kunming Pharmaceutical Artemisinin Derivatives Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kunming Pharmaceutical Artemisinin Derivatives Product Portfolio
  30. 6.5.5 Kunming Pharmaceutical Recent Developments
  31. 6.6 Kerui Nanhai
  32. 6.6.1 Kerui Nanhai Company Information
  33. 6.6.2 Kerui Nanhai Business Overview
  34. 6.6.3 Kerui Nanhai Artemisinin Derivatives Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kerui Nanhai Artemisinin Derivatives Product Portfolio
  36. 6.6.5 Kerui Nanhai Recent Developments
  37. 6.7 Guilin Pharmaceutical
  38. 6.7.1 Guilin Pharmaceutical Company Information
  39. 6.7.2 Guilin Pharmaceutical Business Overview
  40. 6.7.3 Guilin Pharmaceutical Artemisinin Derivatives Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Guilin Pharmaceutical Artemisinin Derivatives Product Portfolio
  42. 6.7.5 Guilin Pharmaceutical Recent Developments
  43. 6.8 Guangxi Xiancaotang Pharmaceutical
  44. 6.8.1 Guangxi Xiancaotang Pharmaceutical Company Information
  45. 6.8.2 Guangxi Xiancaotang Pharmaceutical Business Overview
  46. 6.8.3 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product Portfolio
  48. 6.8.5 Guangxi Xiancaotang Pharmaceutical Recent Developments
  49. 6.9 Guangxi Xiancaotang
  50. 6.9.1 Guangxi Xiancaotang Company Information
  51. 6.9.2 Guangxi Xiancaotang Business Overview
  52. 6.9.3 Guangxi Xiancaotang Artemisinin Derivatives Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Guangxi Xiancaotang Artemisinin Derivatives Product Portfolio
  54. 6.9.5 Guangxi Xiancaotang Recent Developments
  55. 6.10 Novanat Bioresource
  56. 6.10.1 Novanat Bioresource Company Information
  57. 6.10.2 Novanat Bioresource Business Overview
  58. 6.10.3 Novanat Bioresource Artemisinin Derivatives Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novanat Bioresource Artemisinin Derivatives Product Portfolio
  60. 6.10.5 Novanat Bioresource Recent Developments
  61. 6.11 KPC Pharmaceuticals
  62. 6.11.1 KPC Pharmaceuticals Company Information
  63. 6.11.2 KPC Pharmaceuticals Business Overview
  64. 6.11.3 KPC Pharmaceuticals Artemisinin Derivatives Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 KPC Pharmaceuticals Artemisinin Derivatives Product Portfolio
  66. 6.11.5 KPC Pharmaceuticals Recent Developments
  67. 6.12 Botanical Extracts EPZ Ltd
  68. 6.12.1 Botanical Extracts EPZ Ltd Company Information
  69. 6.12.2 Botanical Extracts EPZ Ltd Business Overview
  70. 6.12.3 Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Botanical Extracts EPZ Ltd Artemisinin Derivatives Product Portfolio
  72. 6.12.5 Botanical Extracts EPZ Ltd Recent Developments
  73. 6.13 ArtemiFlow
  74. 6.13.1 ArtemiFlow Company Information
  75. 6.13.2 ArtemiFlow Business Overview
  76. 6.13.3 ArtemiFlow Artemisinin Derivatives Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 ArtemiFlow Artemisinin Derivatives Product Portfolio
  78. 6.13.5 ArtemiFlow Recent Developments
7 North America by Country
  1. 7.1 North America Artemisinin Derivatives Sales by Country
  2. 7.1.1 North America Artemisinin Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Artemisinin Derivatives Sales by Country (2021-2026)
  4. 7.1.3 North America Artemisinin Derivatives Sales Forecast by Country (2027-2032)
  5. 7.2 North America Artemisinin Derivatives Market Size by Country
  6. 7.2.1 North America Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Artemisinin Derivatives Market Size by Country (2021-2026)
  8. 7.2.3 North America Artemisinin Derivatives Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Artemisinin Derivatives Sales by Country
  2. 8.1.1 Europe Artemisinin Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Artemisinin Derivatives Sales by Country (2021-2026)
  4. 8.1.3 Europe Artemisinin Derivatives Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Artemisinin Derivatives Market Size by Country
  6. 8.2.1 Europe Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Artemisinin Derivatives Market Size by Country (2021-2026)
  8. 8.2.3 Europe Artemisinin Derivatives Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Artemisinin Derivatives Sales by Country
  2. 9.1.1 Asia-Pacific Artemisinin Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Artemisinin Derivatives Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Artemisinin Derivatives Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Artemisinin Derivatives Market Size by Country
  6. 9.2.1 Asia-Pacific Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Artemisinin Derivatives Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Artemisinin Derivatives Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Artemisinin Derivatives Sales by Country
  2. 10.1.1 South America Artemisinin Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Artemisinin Derivatives Sales by Country (2021-2026)
  4. 10.1.3 South America Artemisinin Derivatives Sales Forecast by Country (2027-2032)
  5. 10.2 South America Artemisinin Derivatives Market Size by Country
  6. 10.2.1 South America Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Artemisinin Derivatives Market Size by Country (2021-2026)
  8. 10.2.3 South America Artemisinin Derivatives Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Artemisinin Derivatives Sales by Country
  2. 11.1.1 Middle East and Africa Artemisinin Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Artemisinin Derivatives Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Artemisinin Derivatives Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Artemisinin Derivatives Market Size by Country
  6. 11.2.1 Middle East and Africa Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Artemisinin Derivatives Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Artemisinin Derivatives Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Artemisinin Derivatives Value Chain Analysis
  2. 12.1.1 Artemisinin Derivatives Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Artemisinin Derivatives Production Mode & Process
  7. 12.2 Artemisinin Derivatives Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Artemisinin Derivatives Distributors
  10. 12.2.3 Artemisinin Derivatives Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst